Skip to main content
An official website of the United States government
Grant Details

Grant Number: 5R01CA243907-04 Interpret this number
Primary Investigator: Crothers, Kristina
Organization: Seattle Inst For Biomedical/Clinical Res
Project Title: Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV
Fiscal Year: 2022


PROJECT SUMMARY Tobacco use remains the leading preventable cause of death and illness in our society, and smoking rates are disproportionately high among people living with HIV. NCI, nicotine dependence researchers, and HIV clinicians have all called for research to evaluate targeted and tailored smoking cessation programs for smokers living with HIV (SLWH), leading to the current request for applications (RFA-CA-18-027). Research suggests SLWH are largely unaware of the HIV-specific deleterious effects of smoking and often lack motivation and confidence in their ability to quit. For these reasons, we developed the Wellness Intervention for Smokers with HIV (WISH). WISH is grounded in the Information-Motivation-Behavioral Skills (IMB) Model and delivered remotely by mobile phone (voice and text message). The program is designed for all SLWH, regardless of their initial motivation to quit. WISH follows evidence-based, best practice guidelines for nicotine dependence treatment, but is innovative in its use of a more comprehensive wellness approach. That is, the intervention addresses both smoking and a number of other personally relevant health behaviors (such as treatment adherence, stress/mood, nutrition, other substance use, etc.), making it relevant and engaging to all SLWH, not just those ready to stop smoking. For those not yet ready to quit, WISH is designed to build and strengthen motivation and self-efficacy for quitting, while smokers also work on other personal health goals. Once ready to quit smoking, participants receive evidence-based cognitive-behavioral counseling and encouragement to use nicotine replacement therapy (NRT) or other appropriate pharmacotherapy. WISH builds on our extensive experience creating motivationally-enhanced cessation interventions and has been pilot tested with SLWH. In this trial, we will compare the effectiveness of WISH to standard care services offered through the National VA Quitline and the SmokefreeVET texting program, NCI-supported tobacco cessation services available to all Veterans. Participants in both arms can receive phone/ text counseling and have access to pharmacotherapy through VA. Primary outcomes will be biochemically confirmed 7-day point prevalence smoking abstinence and presence of any 24-hour intentional quit attempts. Secondary outcomes will include prolonged abstinence, change in cigarettes per day, intermediate change process outcomes based on the IMB model, as well as metrics of intervention reach and implementation. Consistent with RFA goals, we will also describe comorbidities and explore intervention impact on markers of immune status and mortality risk using the outstanding clinical data resources available through the Veterans Aging Cohort Study (VACS). If effective, WISH could meaningfully reduce smoking among HIV+ Veterans nationwide. To support this goal, dissemination efforts are planned in Year 5 to share the WISH program with the National VA Quitline. Because VA is the largest U.S. provider of HIV care, this research has the potential for significant public health impact.


Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome.
Authors: Mohammad A. , Laboulaye M.A. , Shenhar C. , Dobberfuhl A.D. .
Source: Nature reviews. Urology, 2024 Jul; 21(7), p. 433-449.
EPub date: 2024-02-07.
PMID: 38326514
Related Citations

"I Thought Cancer was a Tobacco Issue": Perspectives of Veterans with and without HIV on Cancer and Other Health Risks Associated with Alcohol and Tobacco/Nicotine Use.
Authors: Briggs E.S. , Thomas R.M. , Frost M.C. , Fletcher O.V. , Crothers K. , Chalal C.K. , Shahrir S.F. , McClure J.B. , Catz S.L. , Williams E.C. .
Source: AIDS and behavior, 2024-06-13; , .
EPub date: 2024-06-13.
PMID: 38869757
Related Citations

Design and methods of a randomized trial testing the novel Wellness Intervention for Smokers Living with HIV (WISH).
Authors: McClure J.B. , Catz S.L. , Chalal C. , Ciuffetelli R. , Coggeshall S. , DeFaccio R.J. , Fleehart S. , Heffner J.L. , Thompson E. , Williams E.C. , et al. .
Source: Contemporary clinical trials, 2021 Nov; 110, p. 106486.
EPub date: 2021-10-27.
PMID: 34776121
Related Citations

COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living With HIV: The Experience of Grantees of the US National Cancer Institute.
Authors: Schnoll R. , Bernstein S.L. , Kaufman A. , Gross R. , Catz S.L. , Cioe P.A. , Hitsman B. , Marhefka S.L. , Pacek L.R. , Vidrine D.J. , et al. .
Source: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021-08-18; 23(9), p. 1629-1632.
PMID: 33657227
Related Citations

The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV.
Authors: Ashare R.L. , Bernstein S.L. , Schnoll R. , Gross R. , Catz S.L. , Cioe P. , Crothers K. , Hitsman B. , Marhefka S.L. , McClure J.B. , et al. .
Source: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021-01-22; 23(2), p. 407-410.
PMID: 32803251
Related Citations

Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV.
Authors: Shahrir S. , Crothers K. , McGinnis K.A. , Chan K.C.G. , Baeten J.M. , Wilson S.M. , Butt A.A. , Pisani M.A. , Baldassarri S.R. , Justice A. , et al. .
Source: Progress in cardiovascular diseases, 2020 Mar-Apr; 63(2), p. 118-124.
EPub date: 2020-01-24.
PMID: 31987807
Related Citations

Back to Top